Why the study?
Chronic inflammation contributes to endothelial damage, but endothelial dysfunction needed assessment via reactive hyperaemia index and flow-mediated dilation in pediatric inflammatory bowel disease patients versus healthy controls.
Does inflammatory bowel disease lead to endothelial dysfunction in pediatric patients?
Does inflammatory bowel disease lead to endothelial dysfunction in pediatric patients?
Pediatric patients with inflammatory bowel disease exhibit endothelial dysfunction measured by flow-mediated dilation, which correlates with intestinal inflammation.
Should not yet change practice in pediatric IBD; leaves open whether endothelial dysfunction predicts or is modified by therapy.
OBJECTIVES: Chronic inflammation plays a central role in the etiology of endothelial damage. Endothelial dysfunction (ED) is the inability of the artery to dilate in response to an endothelial stimulus. We assessed the ED by measuring the reactive hyperaemia index (RHI) and the flow-mediated dilation (FMD) in a cohort of pediatric patients affected by inflammatory bowel disease (IBD) and comparing these parameters to a group of healthy controls (HC). METHODS: Forty-one patients were consecutive enrolled. ED was evaluated by both the plethysmographic RHI method and the measurement of the FMD of brachial artery after occlusion of the blood flow. Differences between patients and controls were assessed by the Mann-Whitney test. In each patient with IBD, the main inflammation markers were detected and correlated to RHI and FMD by a linear regression test. RESULTS: We enrolled 26 (59%) patients with IBD and 18 (41%) HC. When comparing FMD value at diagnosis it was significantly lower in IBD patients than in HC (P = 0.04). This result was confirmed at follow-up, when this difference became even more significant (P = 0.004). A significant indirect correlation was found between FMD and fecal calprotectin (r: 0.17; P = 0.04). No differences were found when comparing RHI. CONCLUSIONS: Our results suggest that inflammation could lead to ED assessed by ultrasound FMD. These data were not confirmed by RHI; however, this could be due to the lack of a standardized pediatric cut-off. More studies are necessary to confirm our data.
No takes yet. Share an insight, caveat, or question.
Andreozzi et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: